Solid growth and earnings weren’t enough for Zebra Technologies investors this quarter. Pfizer boosts full-year guidance on the back of its latest quarter, citing growth in non-Covid offerings and ...

Pfizer raised its full-year outlook on the back of a stronger-than-expected quarter, the latest sign that the drugmaker is finding life beyond the pandemic. Zebra reported third-quarter earnings per ...

Surging memory costs are taking a bite out of Apple’s stock. DuPont reported third-quarter earnings per share of $2.09 from sales of $1.9 billion. Wall Street was looking for EPS of $1.87 from sales ...